A functional role for the histone demethylase UTX in normal and malignant hematopoietic cells

Experimental Hematology

Volumn 40, Issue 6, 2012, Pages

  Liu, Jianing ^a   Mercher, Thomas ^b   Scholl, Claudia ^c   Brumme, Kristina ^a,d   Gilliland, D Gary ^a,e   Zhu, Nan ^a,d  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b INSERM   (France)

^c UNIVERSITY HOSPITAL ULM   (Germany)

^d BOSTON CHILDREN S HOSPITAL   (United States)

^e MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HISTONE DEMETHYLASE; TRANSCRIPTION FACTOR RUNX1; UBIQUITOUSLY TRANSCRIBED TETRATRICOPEPTIDE REPEAT X CHROMOSOME; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL VIABILITY; CHROMATIN IMMUNOPRECIPITATION; COLONY FORMING UNIT; CONTROLLED STUDY; GENE; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; HEMATOPOIESIS; HEMATOPOIETIC CELL; HOMEOSTASIS; HUMAN; HUMAN CELL; IN VITRO STUDY; MALE; MLL1 GENE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN FUNCTION; RUNX1 GENE; SCL GENE;

MAMMALIA; MURINAE;

EID: 84862777232     PISSN: 0301472X     EISSN: 18732399     Source Type: Journal    
DOI: 10.1016/j.exphem.2012.01.017     Document Type: Article

References (57)

1. Teitell M.A., Mikkola H.K. Transcriptional activators, repressors, and epigenetic modifiers controlling hematopoietic stem cell development. Pediatr Res 2006, 59:33R-39R.
2. Shen X., Orkin S.H. Glimpses of the epigenetic landscape. Cell Stem Cell 2009, 4:1-2.
3. Turner B.M. Cellular memory and the histone code. Cell 2002, 111:285-291.
4. Zhao X.D., Han X., Chew J.L., et al. Whole-genome mapping of histone H3 Lys4 and 27 trimethylations reveals distinct genomic compartments in human embryonic stem cells. Cell Stem Cell 2007, 1:286-298.
5. Mikkelsen T.S., Ku M., Jaffe D.B., et al. Genome-wide maps of chromatin state in pluripotent and lineage-committed cells. Nature 2007, 448:553-560.
6. Wei G., Wei L., Zhu J., et al. Global mapping of H3K4me3 and H3K27me3 reveals specificity and plasticity in lineage fate determination of differentiating CD4+ T cells. Immunity 2009, 30:155-167.
7. Agger K., Cloos P.A., Christensen J., et al. UTX and JMJD3 are histone H3K27 demethylases involved in HOX gene regulation and development. Nature 2007, 449:731-734.
8. Lan F., Bayliss P.E., Rinn J.L., et al. A histone H3 lysine 27 demethylase regulates animal posterior development. Nature 2007, 449:689-694.
9. Xiang Y., Zhu Z., Han G., Lin H., Xu L., Chen C.D. JMJD3 is a histone H3K27 demethylase. Cell Res 2007, 17:850-857.
10. Nord A.S., Chang P.J., Conklin B.R., et al. The International Gene Trap Consortium Website: a portal to all publicly available gene trap cell lines in mouse. Nucleic Acids Res 2006, 34:D642-D648.
11. Pearson J.C., Lemons D., McGinnis W. Modulating Hox gene functions during animal body patterning. Nat Rev Genet 2005, 6:893-904.
12. Wang J.K., Tsai M.C., Poulin G., et al. The histone demethylase UTX enables RB-dependent cell fate control. Genes Dev 2010, 24:327-332.
13. Toyota M., Issa J.P. Epigenetic changes in solid and hematopoietic tumors. Semin Oncol 2005, 32:521-530.
14. Ernst T., Chase A.J., Score J., et al. Inactivating mutations of the histone methyltransferase gene EZH2 in myeloid disorders. Nat Genet 2010, 42:722-726.
15. Walter M.J., Ding L., Shen D., et al. Recurrent DNMT3A mutations in patients with myelodysplastic syndromes. Leukemia 2011, 25:1153-1158.
16. Ley T.J., Ding L., Walter M.J., et al. DNMT3A mutations in acute myeloid leukemia. N Engl J Med 2010, 363:2424-2433.
17. Nikoloski G., Langemeijer S.M., Kuiper R.P., et al. Somatic mutations of the histone methyltransferase gene EZH2 in myelodysplastic syndromes. Nat Genet 2010, 42:665-667.
18. Morin R.D., Johnson N.A., Severson T.M., et al. Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas of germinal-center origin. Nat Genet 2010, 42:181-185.
19. Yu B.D., Hess J.L., Horning S.E., Brown G.A., Korsmeyer S.J. Altered Hox expression and segmental identity in Mll-mutant mice. Nature 1995, 378:505-508.
20. Tan Y.C., Chow V.T. Novel human HALR (MLL3) gene encodes a protein homologous to ALR and to ALL-1 involved in leukemia, and maps to chromosome 7q36 associated with leukemia and developmental defects. Cancer Detect Prev 2001, 25:454-469.
21. Krivtsov A.V., Armstrong S.A. MLL translocations, histone modifications and leukaemia stem-cell development. Nat Rev Cancer 2007, 7:823-833.
22. Krivtsov A.V., Twomey D., Feng Z., et al. Transformation from committed progenitor to leukaemia stem cell initiated by MLL-AF9. Nature 2006, 442:818-822.
23. Issaeva I., Zonis Y., Rozovskaia T., et al. Knockdown of ALR (MLL2) reveals ALR target genes and leads to alterations in cell adhesion and growth. Mol Cell Biol 2007, 27:1889-1903.
24. Pasqualucci L., Trifonov V., Fabbri G., et al. Analysis of the coding genome of diffuse large B-cell lymphoma. Nat Genet 2011, 43:830-837.
25. Morin R.D., Mendez-Lago M., Mungall A.J., et al. Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma. Nature 2011, 476:298-303.
26. Cho Y.W., Hong T., Hong S., et al. PTIP associates with MLL3- and MLL4-containing histone H3 lysine 4 methyltransferase complex. J Biol Chem 2007, 282:20395-20406.
27. Smith E.R., Lee M.G., Winter B., et al. Drosophila UTX is a histone H3 Lys27 demethylase that colocalizes with the elongating form of RNA polymerase II. Mol Cell Biol 2008, 28:1041-1046.
28. Lee M.G., Villa R., Trojer P., et al. Demethylation of H3K27 regulates polycomb recruitment and H2A ubiquitination. Science 2007, 318:447-450.
29. Tsai S., Bartelmez S., Sitnicka E., Collins S. Lymphohematopoietic progenitors immortalized by a retroviral vector harboring a dominant-negative retinoic acid receptor can recapitulate lymphoid, myeloid, and erythroid development. Genes Dev 1994, 8:2831-2841.
30. Wojiski S., Guibal F.C., Kindler T., et al. PML-RARalpha initiates leukemia by conferring properties of self-renewal to committed promyelocytic progenitors. Leukemia 2009, 23:1462-1471.
31. Scholl C., Frohling S., Dunn I.F., et al. Synthetic lethal interaction between oncogenic KRAS dependency and STK33 suppression in human cancer cells. Cell 2009, 137:821-834.
32. Rocnik J.L., Okabe R., Yu J.C., et al. Roles of tyrosine 589 and 591 in STAT5 activation and transformation mediated by FLT3-ITD. Blood 2006, 108:1339-1345.
33. Sewack G.F., Ellis T.W., Hansen U. Binding of TATA binding protein to a naturally positioned nucleosome is facilitated by histone acetylation. Mol Cell Biol 2001, 21:1404-1415.
34. Kiel M.J., Yilmaz O.H., Iwashita T., Terhorst C., Morrison S.J. SLAM family receptors distinguish hematopoietic stem and progenitor cells and reveal endothelial niches for stem cells. Cell 2005, 121:1109-1121.
35. Yeager A.M., Levin J., Levin F.C. The effects of 5-fluorouracil on hematopoiesis: studies of murine megakaryocyte-CFC, granulocyte-macrophage-CFC, and peripheral blood cell levels. Exp Hematol 1983, 11:944-952.
36. van Haaften G., Dalgliesh G.L., Davies H., et al. Somatic mutations of the histone H3K27 demethylase gene UTX in human cancer. Nat Genet 2009, 41:521-523.
37. Hu X., Li X., Valverde K., et al. LSD1-mediated epigenetic modification is required for TAL1 function and hematopoiesis. Proc Natl Acad Sci U S A 2009, 106:10141-10146.
38. Saleque S., Kim J., Rooke H.M., Orkin S.H. Epigenetic regulation of hematopoietic differentiation by Gfi-1 and Gfi-1b is mediated by the cofactors CoREST and LSD1. Mol Cell 2007, 27:562-572.
39. Burgold T., Spreafico F., De Santa F., et al. The histone H3 lysine 27-specific demethylase Jmjd3 is required for neural commitment. PLoS One 2008, 3:e3034.
40. Sen G.L., Webster D.E., Barragan D.I., Chang H.Y., Khavari P.A. Control of differentiation in a self-renewing mammalian tissue by the histone demethylase JMJD3. Genes Dev 2008, 22:1865-1870.
41. Friedman A.D. Cell cycle and developmental control of hematopoiesis by Runx1. J Cell Physiol 2009, 219:520-524.
42. Growney J.D., Shigematsu H., Li Z., et al. Loss of Runx1 perturbs adult hematopoiesis and is associated with a myeloproliferative phenotype. Blood 2005, 106:494-504.
43. Ichikawa M., Asai T., Chiba S., Kurokawa M., Ogawa S. Runx1/AML-1 ranks as a master regulator of adult hematopoiesis. Cell Cycle 2004, 3:722-724.
44. Ichikawa M., Goyama S., Asai T., et al. AML1/Runx1 negatively regulates quiescent hematopoietic stem cells in adult hematopoiesis. J Immunol 2008, 180:4402-4408.
45. Ono R., Nosaka T., Hayashi Y. Roles of a trithorax group gene, MLL, in hematopoiesis. Int J Hematol 2005, 81:288-293.
46. Dorshkind K., Witte O. Got MLL? Definitive hematopoiesis requires MLL gene expression. Mol Cell 2004, 13:765-766.
47. Ernst P., Fisher J.K., Avery W., Wade S., Foy D., Korsmeyer S.J. Definitive hematopoiesis requires the mixed-lineage leukemia gene. Dev Cell 2004, 6:437-443.
48. Ernst P., Wang J., Korsmeyer S.J. The role of MLL in hematopoiesis and leukemia. Curr Opin Hematol 2002, 9:282-287.
49. Yagi H., Deguchi K., Aono A., Tani Y., Kishimoto T., Komori T. Growth disturbance in fetal liver hematopoiesis of Mll-mutant mice. Blood 1998, 92:108-117.
50. Hess J.L., Yu B.D., Li B., Hanson R., Korsmeyer S.J. Defects in yolk sac hematopoiesis in Mll-null embryos. Blood 1997, 90:1799-1806.
51. Hall M.A., Curtis D.J., Metcalf D., et al. The critical regulator of embryonic hematopoiesis, SCL, is vital in the adult for megakaryopoiesis, erythropoiesis, and lineage choice in CFU-S12. Proc Natl Acad Sci U S A 2003, 100:992-997.
52. Mikkola H.K., Klintman J., Yang H., et al. Haematopoietic stem cells retain long-term repopulating activity and multipotency in the absence of stem-cell leukaemia SCL/tal-1 gene. Nature 2003, 421:547-551.
53. Curtis D.J., Hall M.A., Van Stekelenburg L.J., Robb L., Jane S.M., Begley C.G. SCL is required for normal function of short-term repopulating hematopoietic stem cells. Blood 2004, 103:3342-3348.
54. Sun W., Downing J.R. Haploinsufficiency of AML1 results in a decrease in the number of LTR-HSCs while simultaneously inducing an increase in more mature progenitors. Blood 2004, 104:3565-3572.
55. Gelsi-Boyer V., Trouplin V., Adelaide J., et al. Mutations of polycomb-associated gene ASXL1 in myelodysplastic syndromes and chronic myelomonocytic leukaemia. Br J Haematol 2009, 145:788-800.
56. Jankowska A.M., Makishima H., Tiu R.V., et al. Mutational spectrum analysis of chronic myelomonocytic leukemia includes genes associated with epigenetic regulation: UTX, EZH2, and DNMT3A. Blood 2011, 118:3932-3941.
57. Xu F., Li X., Wu L., et al. Overexpression of the EZH2, RING1 and BMI1 genes is common in myelodysplastic syndromes: relation to adverse epigenetic alteration and poor prognostic scoring. Ann Hematol 2011, 90:643-653.